Literature DB >> 23782966

Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation*.

Joseph E Levitt1, Carolyn S Calfee, Benjamin A Goldstein, Rosemary Vojnik, Michael A Matthay.   

Abstract

OBJECTIVE: Mortality associated with acute lung injury remains high. Early identification of acute lung injury prior to onset of respiratory failure may provide a therapeutic window to target in future clinical trials. The recently validated Lung Injury Prediction Score identifies patients at risk for acute lung injury but may be limited for routine clinical use. We sought to empirically derive clinical criteria for a pragmatic definition of early acute lung injury to identify patients with lung injury prior to the need for positive pressure ventilation.
DESIGN: Prospective observational cohort study.
SETTING: Stanford University Hospital. PATIENTS: We prospectively evaluated 256 patients admitted to Stanford University Hospital with bilateral opacities on chest radiograph without isolated left atrial hypertension.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Of the 256 patients enrolled, 62 patients (25%) progressed to acute lung injury requiring positive pressure ventilation. Clinical variables (through first 72 hr or up to 6 hr prior to acute lung injury) associated with progression to acute lung injury were analyzed by backward regression. Oxygen requirement, maximal respiratory rate, and baseline immune suppression were independent predictors of progression to acute lung injury. A simple three-component early acute lung injury score (1 point for oxygen requirement > 2-6 L/min or 2 points for > 6 L/min; 1 point each for a respiratory rate ≥ 30 and immune suppression) accurately identified patients who progressed to acute lung injury requiring positive pressure ventilation (area under the receiver-operator characteristic curve, 0.86) and performed similarly to the Lung Injury Prediction Score. An early acute lung injury score greater than or equal to 2 identified patients who progressed to acute lung injury with 89% sensitivity and 75% specificity. Median time of progression from early acute lung injury criteria to acute lung injury requiring positive pressure ventilation was 20 hours.
CONCLUSIONS: This pragmatic definition of early acute lung injury accurately identified patients who progressed to acute lung injury prior to requiring positive pressure ventilation. Pending further validation, these criteria could be useful for future clinical trials targeting early treatment of acute lung injury.

Entities:  

Mesh:

Year:  2013        PMID: 23782966      PMCID: PMC3748809          DOI: 10.1097/CCM.0b013e31828a3d99

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  33 in total

1.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting.

Authors:  C Iribarren; D R Jacobs; S Sidney; M D Gross; M D Eisner
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

Review 3.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

Review 4.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

5.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

6.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

7.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors:  J S Alpert; K Thygesen; E Antman; J P Bassand
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

8.  Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.

Authors:  Roy G Brower; Paul N Lanken; Neil MacIntyre; Michael A Matthay; Alan Morris; Marek Ancukiewicz; David Schoenfeld; B Taylor Thompson
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

9.  Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation.

Authors:  Ognjen Gajic; Saqib I Dara; Jose L Mendez; Adebola O Adesanya; Emir Festic; Sean M Caples; Rimki Rana; Jennifer L St Sauver; James F Lymp; Bekele Afessa; Rolf D Hubmayr
Journal:  Crit Care Med       Date:  2004-09       Impact factor: 7.598

10.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

View more
  33 in total

1.  Timing of Intubation and Clinical Outcomes in Adults With Acute Respiratory Distress Syndrome.

Authors:  Kirsten Neudoerffer Kangelaris; Lorraine B Ware; Chen Yu Wang; David R Janz; Hanjing Zhuo; Michael A Matthay; Carolyn S Calfee
Journal:  Crit Care Med       Date:  2016-01       Impact factor: 7.598

2.  Preventing ARDS: progress, promise, and pitfalls.

Authors:  Jeremy R Beitler; David A Schoenfeld; B Taylor Thompson
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

Review 3.  Applying metabolomics to uncover novel biology in ARDS.

Authors:  Angela J Rogers; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-04-11       Impact factor: 5.464

4.  What's new in ARDS: can we prevent it?

Authors:  Roy G Brower; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2016-03-01       Impact factor: 17.440

5.  A mortality score for acute respiratory distress syndrome: predicting the future without a crystal ball.

Authors:  Raquel S Santos; Pedro L Silva; Jose Rodolfo Rocco; Paolo Pelosi; Patricia Rieken Macêdo Rocco
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

6.  Valproic acid mitigates the inflammatory response and prevents acute respiratory distress syndrome in a murine model of Escherichia coli pneumonia at the expense of bacterial clearance.

Authors:  George Kasotakis; Manuel Galvan; Elizabeth King; Beda Sarkar; Arthur Stucchi; Joseph P Mizgerd; Peter A Burke; Daniel Remick
Journal:  J Trauma Acute Care Surg       Date:  2017-04       Impact factor: 3.313

Review 7.  Ventilator-induced Lung Injury.

Authors:  Jeremy R Beitler; Atul Malhotra; B Taylor Thompson
Journal:  Clin Chest Med       Date:  2016-10-14       Impact factor: 2.878

Review 8.  RNAi therapeutic strategies for acute respiratory distress syndrome.

Authors:  Melissa L Jagrosse; David A Dean; Arshad Rahman; Bradley L Nilsson
Journal:  Transl Res       Date:  2019-07-27       Impact factor: 7.012

Review 9.  Approach to the patient with the acute respiratory distress syndrome.

Authors:  David R Janz; Lorraine B Ware
Journal:  Clin Chest Med       Date:  2014-09-26       Impact factor: 2.878

10.  Publication trends of research on acute lung injury and acute respiration distress syndrome during 2009-2019: a 10-year bibliometric analysis.

Authors:  Chen Wang; Xuren Wang; Xisha Long; Demeng Xia; Daofeng Ben; Yin Wang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.